Nao You (脑优)脑优

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

双氢麦角毒碱是一种在国家药监局注册认定的药品。该药品含有双氢麦角毒碱-80638d33等成分。

该药品关联的活性成分包括:双氢麦角毒碱Shuangqing Maijiao Dujian。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:牡丹江灵泰药业股份有限公司Chinese legal name: 牡丹江灵泰药业股份有限公司。

您可以探索含有相同成分的其他药品:双氢麦角毒碱-80638d33成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 脑优) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 双氢麦角毒碱Shuangqing Maijiao Dujian.

Manufacturers recorded for this product: 牡丹江灵泰药业股份有限公司Chinese legal name: 牡丹江灵泰药业股份有限公司.

Explore other medicines containing the same ingredient: 双氢麦角毒碱 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 脑优Recorded Chinese name: 脑优
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 1ml:3mg/支1 mL:3 mg/unit

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 牡丹江灵泰药业股份有限公司Chinese legal name: 牡丹江灵泰药业股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20053760

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20053760

Manufacturer

Chinese legal name: 牡丹江灵泰药业股份有限公司

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20053760

生产企业

牡丹江灵泰药业股份有限公司

适应症

脑供血不足、急性缺血性脑卒中、卒中或脑外伤后遗症及老年性痴呆。外周血管病(血管栓赛性脉管炎、雷诺氏病、手足发绀、动脉硬化和糖尿病引起的功能紊乱)、颈部综合症、血管性耳蜗前庭综合症、血管性视网膜病变。血管性偏头痛和其他头痛、高血压。

用法用量

静滴或缓慢推助,每次一支,每日一次或两次。肌注或皮下注射;每次一支,每日两次。

不良反应

参见详细说明

禁忌

对本品过敏者,血管疾病患者、动脉炎患者、冠心病患者、严重的肝功能损伤患者及脓血症患者禁用。孕妇及哺乳期患者禁用。

注意事项

参见详细说明

规格

1ml:3mg/支

证据Evidence

  • 批准文号: 国药准字H20053760
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.